Skip to main content
. 2011 Feb 18;32(6):1617–1624. doi: 10.1007/s00296-011-1807-0

Fig. 3.

Fig. 3

European League Against Rheumatism responses. IFX infliximab. *P < 0.05 versus week 4 for good responders (Fisher’s exact test)